tiprankstipranks
Trending News
More News >
Intellia Therapeutics (NTLA)
NASDAQ:NTLA

Intellia Therapeutics (NTLA) Revenue

Compare
4,585 Followers

Intellia Therapeutics Revenue

Intellia Therapeutics had a revenue of 13.78M in the quarter ending Sep 30, 2025, with -3.25%. This bring the company's revenue in the last twelve months to 57.53M, Decreased 8.84%. In the fiscal year ending Dec 31, 2024, Intellia Therapeutics had annual revenue of 57.88M with 59.55% growth.
Revenue (ttm)
57.53M
Revenue Growth
33.52%
P/S Ratio
19.11
Revenue/Employee
$143,615
Employees
403
Market Cap
$1.11B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
57.88M21.60M+159.55%
Dec 31, 2023
36.27M-15.85M+69.60%
Dec 31, 2022
52.12M19.07M+157.69%
Dec 31, 2021
33.05M-24.94M+56.99%
Dec 31, 2020
57.99M14.89M+134.55%
Dec 31, 2019
43.10M12.67M+141.63%
Dec 31, 2018
30.43M4.32M+116.53%
Dec 31, 2017
26.12M9.64M+158.49%
Dec 31, 2016
16.48M